Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
AROC-3 by Arrowhead Pharmaceuticals for Glomerulonephritis: Likelihood of Approval
AROC-3 is under clinical development by Arrowhead Pharmaceuticals and currently in Phase II for Glomerulonephritis. According to GlobalData, Phase II...
Data Insights
AROC-3 by Arrowhead Pharmaceuticals for IgA Nephropathy (Berger's Disease): Likelihood of Approval
AROC-3 is under clinical development by Arrowhead Pharmaceuticals and currently in Phase II for IgA Nephropathy (Berger's Disease). According to...